The cost-effectiveness of treatment as prevention: analysis of the HPTN 052 trial

被引：0

作者：

Walensky, R. P. ^{[1
,2
,6
]}

Ross, E. L. ^{[1
]}

Kumarasamy, N. ^{[7
]}

Wood, R. ^{[8
,9
]}

Noubary, F. ^{[1
]}

Paltiel, A. D. ^{[10
]}

Nakamura, Y. M. ^{[1
]}

Godbole, S. ^{[11
]}

Hosseinipour, M. ^{[12
,13
]}

Hakim, J. G. ^{[14
]}

Kumwenda, J. ^{[15
]}

Makhema, J. ^{[5
]}

Akelo, V. ^{[16
]}

Panchia, R. ^{[17
]}

Sanne, I. ^{[18
]}

Weinstein, M. C. ^{[4
]}

Losina, E. ^{[3
,6
,19
]}

Mayer, K. H. ^{[20
]}

Grinsztejn, B. ^{[21
]}

Pilotto, J. ^{[22
,23
]}

Chariyalertsak, S. ^{[24
]}

Santos, B. ^{[25
]}

Chen, Y. Q. ^{[26
]}

Wang, L. ^{[26
]}

Li, X. ^{[26
]}

McCauley, M. ^{[27
]}

Gamble, T. ^{[28
]}

Piwowar-Manning, E. ^{[29
]}

Cottle, L. ^{[30
]}

Hoffman, I. ^{[31
]}

Eron, J. ^{[31
]}

Gallant, J. ^{[29
]}

Swindells, S. ^{[32
]}

Taha, T. ^{[33
]}

Nielsen-Saines, K. ^{[34
]}

Celentano, D. ^{[33
]}

Essex, M. ^{[4
]}

Elharrar, V. ^{[35
]}

Burns, D. ^{[35
]}

Seage, G. R. ^{[4
]}

Cohen, M. S. ^{[31
]}

Freedberg, K. A. ^{[1
,2
,19
]}

机构：

[1] Massachusetts Gen Hosp, Boston, MA 02114 USA

[2] Harvard Univ, Sch Med, Boston, MA USA

[3] Harvard Ctr AIDS Res, Boston, MA USA

[4] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA

[5] Botswana Harvard AIDS Inst, Gaborone, Botswana

[6] Brigham & Womens Hosp, Boston, MA 02115 USA

[7] YR Gaitonade Ctr AIDS Res & Educ, Madras, Tamil Nadu, India

[8] Univ Cape Town, ZA-7925 Cape Town, South Africa

[9] Desmond Tutu HIV Ctr, Cape Town, South Africa

[10] Yale Univ, Sch Med, New Haven, CT USA

[11] NARI, Pune, Maharashtra, India

[12] Univ N Carolina Chapel Hill, Lilongwe, Malawi

[13] UNC Project Malawi, Lilongwe, Malawi

[14] Univ Zimbabwe, Dept Med, Harare, Zimbabwe

[15] Coll Med Johns Hopkins Project, Blantyre, Malawi

[16] KEMRI CDC Res & Publ Hlth Collaborat, Kisumu, Kenya

[17] Univ Witwatersrand, PHRU, Johannesburg, South Africa

[18] Univ Witwatersrand, Dept Med, Johannesburg, South Africa

[19] Boston Univ, Sch Publ Hlth, Boston, MA USA

[20] Fenway Inst, Boston, MA USA

[21] Fiocruz MS, Inst Pesquisa Clin Evandro Chagas, BR-21045900 Rio De Janeiro, Brazil

[22] Fiocruz MS, Hosp Geral Nova Iguacu, BR-21045900 Rio De Janeiro, Brazil

[23] Fiocruz MS, Lab AIDS & Imunol Mol IOC, BR-21045900 Rio De Janeiro, Brazil

[24] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand

[25] Hosp Nossa Senhora da Conceicao, Porto Alegre, RS, Brazil

[26] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA

[27] FHI 360, Washington, DC USA

[28] FHI 360, Durham, NC USA

[29] Johns Hopkins Sch Med, Baltimore, MD USA

[30] SCHARP, Seattle, WA USA

[31] Univ N Carolina, Sch Med, Chapel Hill, NC USA

[32] Univ Nebraska Med Ctr, Omaha, NE USA

[33] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA

[34] Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Los Angeles, CA 90095 USA

[35] NIAID, NIH, Bethesda, MD 20892 USA

来源：

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2012年 / 15卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：116 / 117

页数：2

共 50 条

[31] Cost-effectiveness of stroke prevention
Ebrahim, S
BRITISH MEDICAL BULLETIN, 2000, 56 (02) : 557 - 570
[32] Prevention of Rhesus-alloimmunisation: a cost-effectiveness analysis
Zourob, Haly S.
Abu El Aish, Khaled I.
LANCET, 2022, 399 : 31 - 31
[33] Aspirin strategies for preeclampsia prevention: a cost-effectiveness analysis
Mallampati, Divya
Grobman, William
Rouse, Dwight
Werner, Erika
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2019, 220 (01) : S488 - S489
[34] Cost-Effectiveness Analysis of Tdap in the Prevention of Pertussis in the Elderly
McGarry, Lisa J.
Krishnarajah, Girishanthy
Hill, Gregory
Skornicki, Michelle
Pruttivarasin, Narin
Masseria, Cristina
Arondekar, Bhakti
Pelton, Stephen I.
Weinstein, Milton C.
PLOS ONE, 2013, 8 (09):
[35] TUBERCULOSIS PREVENTION - COST-EFFECTIVENESS ANALYSIS OF ISONIAZID CHEMOPROPHYLAXIS
ROSE, DN
SCHECHTER, CB
FAHS, MC
SILVER, AL
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 1988, 4 (02) : 102 - 109
[36] A decade of investment in infection prevention: A cost-effectiveness analysis
Dick, Andrew W.
Perencevich, Eli N.
Pogorzelska-Maziarz, Monika
Zwanziger, Jack
Larson, Elaine L.
Stone, Patricia W.
AMERICAN JOURNAL OF INFECTION CONTROL, 2015, 43 (01) : 4 - 9
[37] A prospective cost-effectiveness analysis for the prevention of asthma in children
Gutierrez De Mesa, E.
Hidalgo, I.
Christidis, P.
Ciscar, Jc
Vegas, E.
Ibarreta, D.
EUROPEAN JOURNAL OF PUBLIC HEALTH, 2006, 16 : 137 - 137
[38] Cost-effectiveness analysis and HIV prevention community planning
Pinkerton, SD
Holtgrave, DR
Willingham, M
Goldstein, E
AIDS & PUBLIC POLICY JOURNAL, 1998, 13 (03) : 115 - 127
[39] Prevention of osteoporosis - A cost-effectiveness analysis regarding fractures
Norlund, A
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1996, : 42 - 45
[40] Exercise for the Prevention of Preterm Birth: A Cost-Effectiveness Analysis
Speranza, Rosa
Sargent, James
Savitsky, Leah
Caughey, Aaron B.
OBSTETRICS AND GYNECOLOGY, 2018, 131 : 51S - 51S

← 1 2 3 4 5 →